Update on Type 2 Diabetes Management: The Heart of the Matter
Dates and Times
Start: 10/16/2019 7:45 AM
End: 10/16/2019 8:45 AM
1) Learn about cardiovascular risk reduction associated with use of anti diabetic drugs in the class of GLP-1 receptor agonists
2) Learn bout the cardiovascular risk reduction associated with the use of anti-diabetic drugs in the class of SGLT2 inhibitors
3) prevention of adverse reactions associated with GLP-1 Receptor agonists and SGLT2 inhibitors
4) How to prevent increased cardiovascular risk associated with T2DM
Lecture Hall 2
101 Nicolls Road
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.